US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist

1.2500
+0.0200+1.63%

Trading Nov 22 12:30 ET

15.12MMarket Cap-592P/E (TTM)

NRX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-47.97%3.02M

-13.90%7.05M

-36.43%6M

-37.21%27.84M

-55.44%4.41M

-36.46%5.81M

-14.71%8.19M

-39.92%9.44M

-61.71%44.34M

-81.33%9.89M

Selling and administrative expenses

-3.33%2.41M

4.45%4.25M

-26.53%4.25M

-47.94%14.22M

-65.54%1.87M

-50.24%2.49M

-38.80%4.07M

-43.41%5.79M

-63.56%27.31M

-88.33%5.43M

-General and administrative expense

-3.33%2.41M

4.45%4.25M

-26.53%4.25M

-47.94%14.22M

-65.54%1.87M

-50.24%2.49M

-38.80%4.07M

-43.41%5.79M

-63.56%27.31M

-88.33%5.43M

Research and development costs

-81.56%611K

-27.60%2.8M

-52.11%1.75M

-21.47%13.37M

-43.13%2.53M

-19.74%3.31M

30.93%3.87M

-33.43%3.65M

-15.95%17.03M

-30.52%4.46M

Other operating expenses

----

--250K

--0

----

--250K

----

Operating profit

47.97%-3.02M

13.90%-7.05M

36.43%-6M

37.21%-27.84M

55.44%-4.41M

36.46%-5.81M

14.71%-8.19M

39.92%-9.44M

61.71%-44.34M

81.33%-9.89M

Net non-operating interest income expense

-92.41%6K

-95.17%7K

-230.13%-203K

50.20%374K

-104.51%-6K

-16.84%79K

530.43%145K

5,300.00%156K

1,483.33%249K

6,750.00%133K

Non-operating interest income

-94.96%6K

-95.17%7K

-82.69%27K

98.39%494K

-43.08%74K

25.26%119K

530.43%145K

--156K

--249K

--130K

Non-operating interest expense

--0

--230K

--120K

2,766.67%80K

--40K

--0

-250.00%-3K

Other net income (expense)

518.32%1.39M

-26.71%-854K

81.42%-327K

-162.03%-2.69M

116.46%80K

-800.00%-333K

-125.97%-674K

-177.88%-1.76M

-80.96%4.33M

-102.15%-486K

Gain on sale of security

534.62%165K

263.64%18K

-175.00%-9K

-92.16%20K

-136.84%-7K

170.27%26K

-109.48%-11K

-92.36%12K

-84.93%255K

-97.81%19K

Special income (charges)

---127K

----

--0

----

-78.24%4.58M

--0

-Less：Restructuring and merger&acquisition

----

--0

----

78.12%-4.58M

--0

-Less:Other special charges

--127K

----

Other non- operating income (expenses)

477.44%1.36M

-31.52%-872K

82.05%-318K

-436.04%-2.71M

--87K

---359K

---663K

---1.77M

---505K

----

Income before tax

73.23%-1.62M

9.41%-7.9M

40.86%-6.53M

24.16%-30.15M

57.70%-4.33M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

57.28%-39.75M

66.32%-10.24M

Income tax

Net income

73.23%-1.62M

9.41%-7.9M

40.86%-6.53M

24.16%-30.15M

57.70%-4.33M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

57.28%-39.75M

66.32%-10.24M

Net income continuous Operations

73.23%-1.62M

9.41%-7.9M

40.86%-6.53M

24.16%-30.15M

57.70%-4.33M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

57.28%-39.75M

66.32%-10.24M

Minority interest income

Net income attributable to the parent company

73.23%-1.62M

9.41%-7.9M

40.86%-6.53M

24.16%-30.15M

57.70%-4.33M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

57.28%-39.75M

66.32%-10.24M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

73.23%-1.62M

9.41%-7.9M

40.86%-6.53M

24.14%-30.16M

57.61%-4.34M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

88.61%-39.75M

66.32%-10.24M

Basic earnings per share

79.73%-0.15

38.02%-0.75

55.42%-7.4

33.33%-4

65.33%-0.52

47.14%-0.74

-10.00%-1.21

-690.48%-16.6

91.94%-6

70.99%-1.5

Diluted earnings per share

79.73%-0.15

38.02%-0.75

55.42%-7.4

33.33%-4

65.33%-0.52

47.14%-0.74

-10.00%-1.21

-690.48%-16.6

91.94%-6

70.99%-1.5

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-47.97%3.02M	-13.90%7.05M	-36.43%6M	-37.21%27.84M	-55.44%4.41M	-36.46%5.81M	-14.71%8.19M	-39.92%9.44M	-61.71%44.34M	-81.33%9.89M
Selling and administrative expenses	-3.33%2.41M	4.45%4.25M	-26.53%4.25M	-47.94%14.22M	-65.54%1.87M	-50.24%2.49M	-38.80%4.07M	-43.41%5.79M	-63.56%27.31M	-88.33%5.43M
-General and administrative expense	-3.33%2.41M	4.45%4.25M	-26.53%4.25M	-47.94%14.22M	-65.54%1.87M	-50.24%2.49M	-38.80%4.07M	-43.41%5.79M	-63.56%27.31M	-88.33%5.43M
Research and development costs	-81.56%611K	-27.60%2.8M	-52.11%1.75M	-21.47%13.37M	-43.13%2.53M	-19.74%3.31M	30.93%3.87M	-33.43%3.65M	-15.95%17.03M	-30.52%4.46M
Other operating expenses	----	----	----	--250K	--0	----	--250K	----	----	----
Operating profit	47.97%-3.02M	13.90%-7.05M	36.43%-6M	37.21%-27.84M	55.44%-4.41M	36.46%-5.81M	14.71%-8.19M	39.92%-9.44M	61.71%-44.34M	81.33%-9.89M
Net non-operating interest income expense	-92.41%6K	-95.17%7K	-230.13%-203K	50.20%374K	-104.51%-6K	-16.84%79K	530.43%145K	5,300.00%156K	1,483.33%249K	6,750.00%133K
Non-operating interest income	-94.96%6K	-95.17%7K	-82.69%27K	98.39%494K	-43.08%74K	25.26%119K	530.43%145K	--156K	--249K	--130K
Non-operating interest expense	--0	--0	--230K	--120K	2,766.67%80K	--40K	--0	--0	--0	-250.00%-3K
Other net income (expense)	518.32%1.39M	-26.71%-854K	81.42%-327K	-162.03%-2.69M	116.46%80K	-800.00%-333K	-125.97%-674K	-177.88%-1.76M	-80.96%4.33M	-102.15%-486K
Gain on sale of security	534.62%165K	263.64%18K	-175.00%-9K	-92.16%20K	-136.84%-7K	170.27%26K	-109.48%-11K	-92.36%12K	-84.93%255K	-97.81%19K
Special income (charges)	---127K	----	----	--0	--0	--0	----	----	-78.24%4.58M	--0
-Less：Restructuring and merger&acquisition	----	----	----	--0	----	----	----	----	78.12%-4.58M	--0
-Less:Other special charges	--127K	----	----	----	----	----	----	----	----	----
Other non- operating income (expenses)	477.44%1.36M	-31.52%-872K	82.05%-318K	-436.04%-2.71M	--87K	---359K	---663K	---1.77M	---505K	----
Income before tax	73.23%-1.62M	9.41%-7.9M	40.86%-6.53M	24.16%-30.15M	57.70%-4.33M	33.26%-6.06M	-24.85%-8.72M	17.91%-11.04M	57.28%-39.75M	66.32%-10.24M
Income tax
Net income	73.23%-1.62M	9.41%-7.9M	40.86%-6.53M	24.16%-30.15M	57.70%-4.33M	33.26%-6.06M	-24.85%-8.72M	17.91%-11.04M	57.28%-39.75M	66.32%-10.24M
Net income continuous Operations	73.23%-1.62M	9.41%-7.9M	40.86%-6.53M	24.16%-30.15M	57.70%-4.33M	33.26%-6.06M	-24.85%-8.72M	17.91%-11.04M	57.28%-39.75M	66.32%-10.24M
Minority interest income
Net income attributable to the parent company	73.23%-1.62M	9.41%-7.9M	40.86%-6.53M	24.16%-30.15M	57.70%-4.33M	33.26%-6.06M	-24.85%-8.72M	17.91%-11.04M	57.28%-39.75M	66.32%-10.24M
Preferred stock dividends
Other preferred stock dividends				9K					0
Net income attributable to common stockholders	73.23%-1.62M	9.41%-7.9M	40.86%-6.53M	24.14%-30.16M	57.61%-4.34M	33.26%-6.06M	-24.85%-8.72M	17.91%-11.04M	88.61%-39.75M	66.32%-10.24M
Basic earnings per share	79.73%-0.15	38.02%-0.75	55.42%-7.4	33.33%-4	65.33%-0.52	47.14%-0.74	-10.00%-1.21	-690.48%-16.6	91.94%-6	70.99%-1.5
Diluted earnings per share	79.73%-0.15	38.02%-0.75	55.42%-7.4	33.33%-4	65.33%-0.52	47.14%-0.74	-10.00%-1.21	-690.48%-16.6	91.94%-6	70.99%-1.5
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data